The Trip Treatment: Research into psychedelics, shut down for decades, is now yielding exciting results

Trip

Click Here to Read: The Trip Treatment: Research into psychedelics, shut down for decades, is now yielding exciting results. By Mechael Pollan in The New Yorker in the Gebruary 9, 2015 issue.

Psilocybin may be useful in treating anxiety, addiction, and depression, and in studying the neurobiology of mystical experience.
CREDIT ILLUSTRATION BY STEPHEN DOYLE